Tag: Nephrology
-
India’s CKD Crisis: Second-Highest Global Cases in 2023, Lancet Study
Overview: A Widespread Kidney Health Challenge A global study published in The Lancet has revealed that India recorded the second-highest number of people living with chronic kidney disease (CKD) in 2023, totaling about 138 million. Only China registered more cases, with roughly 152 million. This finding underscores a kidney health crisis affecting a significant portion…
-
Sobi to Unveil New One-Year Data on pegcetacoplan’s Efficacy in C3G and IC-MPGN, Plus NASP Outcomes at ASN Kidney Week 2025
Overview of the Upcoming ASN Kidney Week Presentations Stockholm-based biopharmaceutical company Sobi is set to share new clinical data at ASN Kidney Week 2025, taking place from November 5–9. The presentations will focus on pegylated C3 inhibitor pegcetacoplan, marketed as Aspaveli in Europe and Empaveli in the U.S., exploring its one-year efficacy in two rare…
-
Sobi to Unveil One-Year Pegcetacoplan Data for C3G, IC-MPGN and NASP at ASN Kidney Week 2025
Overview: Sobi to Share New Pegcetacoplan Data at ASN Kidney Week 2025 Sobi, a global biopharmaceutical company focused on rare diseases, has announced that new data on pegcetacoplan will be presented at ASN Kidney Week 2025, taking place from November 5–9. The presentations will explore one-year efficacy data for pegcetacoplan in C3 glomerulopathy (C3G) and…
-
Sobi to Unveil One-Year Data on pegcetacoplan for C3G and IC-MPGN, Plus NASP Results at ASN Kidney Week 2025
Overview of the Upcoming ASN Kidney Week Presentations Biopharma company Sobi has announced that new data will be shared at ASN Kidney Week 2025, taking place November 5–9. The conference program includes one-year efficacy data for pegylated C3G therapy pegcetacoplan (marketed as Aspaveli/Empaveli) in two glomerular diseases—the rare kidney conditions C3 glomerulopathy (C3G) and primary…
-
Endoscopic Intervention in Renal UGIB: Predictive Model
Overview Upper gastrointestinal bleeding (UGIB) presents a significant clinical challenge when it occurs in patients with renal insufficiency. Endoscopic intervention is a cornerstone of UGIB management, but its effectiveness may be limited in those with impaired kidney function. This article reviews efficacy thresholds for endoscopy in this high-risk group and outlines a predictive model to…
-
Endoscopic Intervention in Renal Failure UGIB: Efficacy & Models
Introduction Upper gastrointestinal bleeding (UGIB) poses a significant risk in patients with renal insufficiency. Endoscopic intervention is a standard therapy aimed at stopping bleeding and reducing mortality. However, the effectiveness of endoscopy may vary according to kidney function, comorbidities, and the severity of bleeding. This article explores disease severity thresholds where endoscopic intervention may fail…
-
Endoscopic Intervention in Renal Failure with Upper Gastrointestinal Bleeding: Efficacy and Predictive Modeling
Introduction Upper gastrointestinal bleeding (UGIB) represents a critical challenge in patients with renal insufficiency. Renal impairment complicates hemostasis, alters pharmacokinetics of medications, and can influence the success rates of endoscopic interventions. This article reviews the efficacy of endoscopy in this high‑risk population, identifies disease severity thresholds where intervention may fail to reduce mortality, and describes…
-
Mercury in Delhi Air: How it Impacts the Kidneys and What Residents Can Do
Mercury in Delhi’s Air: A Hidden Kidney Risk New research shows that the air in India’s capital contains worrying levels of mercury, a toxic heavy metal with serious implications for kidney health. The World Health Organization has long flagged mercury as one of the most dangerous chemicals to public health, and recent studies confirm that…
-
Mercury in Delhi Air: How This Heavy Metal Threatens Kidneys and Public Health
Mercury in Delhi’s Air: A Growing Health Concern Recent scientific findings reveal a troubling reality: Delhi’s air contains elevated levels of mercury, a toxic heavy metal that can silently affect multiple body systems. While much attention focuses on particulate matter and ozone, mercury’s unique chemistry and toxicity demand equal scrutiny. The latest research indicates that…
-
Mercury in Delhi Air: How It Impacts Kidney Health
Mercury in Delhi’s Air: A silent threat to kidney health New scientific findings show that Delhi’s air contains elevated levels of mercury, a toxic heavy metal that can harm multiple organs, especially the kidneys. The World Health Organization lists mercury among the most dangerous chemicals for public health, and recent research highlights the potential impact…